The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that. The post GSK’s share price looks a steal to me ...

A devastating 77-magnitude earthquake struck Myanmar unleashing energy equal to 334 atomic bombs Experts warn of lasting ...

A new Cambridge, UK-based biotech says it wants to become a world leader in developing drugs based on microbiome biology. The microbiome is made up of trillions of bacteria that live in the human ...

Bayer has abandoned development of its investigational P2X3 receptor antagonist eliapixant, despite promising efficacy data in clinical trials, on what appears to be safety grounds. The decision ...